a16z Podcast: How To Raise Money From A Venture Investor
So you've decided raising venture capital is the best fundraising strategy for your startup. Now what? In this second of a 3-part series, a16z Managing Partner Scott Kupor shares actionable fundraisin...
18 Heinä 201933min
a16z Podcast: How To Understand And Choose A Venture Investor
Incentives matter. So understanding the incentives of venture capitalists will help you decide if raising money from a venture investor makes sense for your business. In this first of a 3-part series,...
17 Heinä 201926min
a16z Podcast: Beyond Software, to Talent and Culture
with Marc Andreessen (@pmarca), Ben Horowitz (@bhorowitz), and Tyler Cowen (@tylercowen) Continuing our 10-year anniversary series since the founding of Andreessen Horowitz (aka "a16z"), we’re resurfa...
4 Heinä 201938min
a16z Podcast: Beyond Zero Sum, Again
with Marc Andreessen (@pmarca), Ben Horowitz (@bhorowitz), and Steven Johnson (@stevenbjohnson) Continuing our 10-year anniversary series since the founding of Andreessen Horowitz (aka "a16z"), we’re ...
4 Heinä 201942min
a16z Podcast: Beyond Software Eating the World
with Marc Andreessen (@pmarca), Ben Horowitz (@bhorowitz), Scott Kupor (@skupor), and Sonal Chokshi (@smc90) Continuing our 10-year anniversary series since the founding of Andreessen Horowitz (aka "a...
4 Heinä 201941min
a16z Podcast: Beyond Disruption Theory
with Marc Andreessen (@pmarca), Ben Horowitz (@bhorowitz), and Michael Copeland Continuing our 10-year anniversary series since the founding of Andreessen Horowitz (aka "a16z"), we’re resurfacing some...
4 Heinä 201917min
a16z Podcast: Entrepreneurs, Then and Now
with Marc Andreessen (@pmarca), Ben Horowitz (@bhorowitz), and Stewart Butterfield (@stewart) A lot in technology -- and venture -- happens in decades. New cycles of technology come and go, including ...
28 Kesä 201944min
a16z Podcast: Damage-free Genome Editing -- Next in CRISPR
Two recent scientific journal papers show what's possible when CRISPR moves from cutting DNA tool to a full-fledged platform -- expanding its toolkit for medicine across R&D, therapeutics, and diagnos...
26 Kesä 201915min
